August 2023
1. THEOFILIS P, Vordoni A, Kalaitzidis RG
   Novel therapeutic approaches in the management of chronic kidney disease: a narrative review.
   Postgrad Med. 2023;135:543-550.
   

   >> Share

   
   June 2023
2. LIU T, Song J, Zuo R, Sun L, et al
   The effects of cardiometabolic factors on the association between serum uric acid and risk of all-cause mortality in adults with congestive heart failure.
   Postgrad Med. 2023;135:511-518.
   

   >> Share

   
   May 2023
3. NAWAKA N, Rattanawan C, Pussadhamma B, Wutthimanop A, et al
   The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease.
   Postgrad Med. 2023;135:410-417.
   

   >> Share

   
   January 2022
4. FERNANDEZ-PLANELLES MC, Palazon-Bru A, Calvo-Perez M, Pico-Alfonso AM, et al
   Impact of a clinical pathway on cardiovascular risk in patients with diabetes.
   Postgrad Med. 2022;134:96-103.
   

   >> Share

   
   
5. LOPEZ-CANDALES A, Mathur P, Mounsey JP, Veeraputhiran M, et al
   Is heart rate in post-hematopoietic stem cell transplant patients clinically relevant?
   Postgrad Med. 2022;134:7-10.
   

   >> Share

   
   September 2021
6. ZHANG M, Wu S, Xu S, Chen S, et al
   Impact of monocyte to high-density lipoprotein ratio on the identification of prevalent coronary heart disease: insights from a general population.
   Postgrad Med. 2021;133:822-829.
   

   >> Share

   
   August 2021
7. FENG R, Guo X, Kou Y, Xu X, et al
   Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis.
   Postgrad Med. 2021;133:626-638.
   

   >> Share

   
   May 2021
8. YAN L, Huangfu C, Yang N, Li R, et al
   Sex- related differences in the factors associated with outcomes among patients with strokes of undetermined source: a hospital-based follow-up study.
   Postgrad Med. 2021;133:428-435.
   

   >> Share

   
   March 2021
9. YAMAN S, Ozdemir D, Akman BT, Cakir B, et al
   Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia.
   Postgrad Med. 2021;133:146-153.
   

   >> Share

   
   January 2021
10. TRIVEDI K, Le V, Nelson JR
    The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention.
    Postgrad Med. 2021;133:28-41.
    

    >> Share

    
    August 2020
11. KARA E, Tecen Yucel K, Bayraktar-Ekincioglu A, Demirkan K, et al
    Evaluation of internal medicine physicians' attitudes toward the treatment of dyslipidemia.
    Postgrad Med. 2020;132:538-543.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share